Amino-acid PET based dose painting radiation therapy in glioblastoma patients Ghent University
Glioblastoma is the most aggressive and most common primary brain tumour in adults. Even with the current state-ofthe-
art treatment of postoperative combined radiation therapy (RT) and chemotherapy, the median survival is only 12-14
months. Therefore, there is an urgent need for alternative treatment strategies in glioblastoma patients. In this proposal,
the focus is ...